Back to search

United States· US:15631-0278_ca3aa7a8-9d23-3d66-e053-2a95a90a05be

LYCOPODIUM CLAVATUM

A medicinal product containing lycopodium clavatum spore, registered in United States by Rxhomeo Private Limited d.b.a. Rxhomeo, Inc.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedLYCOPODIUM CLAVATUMATC—REGISTER NO.US:15631-0278_ca3aa7a…PACKS LISTED16CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
LYCOPODIUM CLAVATUM SPORE
Manufacturer
Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 16

  • ndc11
    1563102780
    100 PELLET in 1 PACKAGE (15631-0278-0)
  • ndc11
    1563102781
    200 PELLET in 1 PACKAGE (15631-0278-1)
  • ndc11
    1563102782
    400 PELLET in 1 PACKAGE (15631-0278-2)
  • ndc11
    1563102783
    750 PELLET in 1 PACKAGE (15631-0278-3)
  • ndc11
    1563102784
    2500 PELLET in 1 PACKAGE (15631-0278-4)
  • ndc11
    1563102785
    12500 PELLET in 1 PACKAGE (15631-0278-5)
  • ndc11
    1563102786
    500 PELLET in 1 PACKAGE (15631-0278-6)
  • ndc11
    1563102787
    1000 PELLET in 1 PACKAGE (15631-0278-7)
  • ndc11
    15631-0278-0
  • ndc11
    15631-0278-1
  • ndc11
    15631-0278-2
  • ndc11
    15631-0278-3
  • ndc11
    15631-0278-4
  • ndc11
    15631-0278-5
  • ndc11
    15631-0278-6
  • ndc11
    15631-0278-7

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lycopodium clavatum spore in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lycopodium clavatum spore products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Latvia · Likopodijs Rff

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c2ae5a6d-38e5-491b-b505-ab8fa2b079ba
GET /v1/drugs/c2ae5a6d-38e5-491b-b505-ab8fa2b079ba?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "1",
  "substance": "LYCOPODIUM CLAVATUM SPORE",
  "productndc": "15631-0278",
  "dosage_form": "PELLET",
  "dea_schedule": null,
  "strength_unit": "[hp_X]/1",
  "application_number": null,
  "marketing_category": "UNAPPROVED HOMEOPATHIC"
}

See everything about lycopodium clavatum spore.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.